Professor Jean-Michel Foidart graduated in Gynecology from the University of Liège and also obtained a PhD in cell biology and biochemistry, before directing its Department of Gynecology-Obstetrics.
Co-founder of Mithra, he is the author of more than 1300 publications on women’s health and experimental oncology. Professor Foidart holds the Francqui Chair, Doctor Honoris Causa of the Pierre and Marie Curie University of Paris and the Paul Sabatier University of Toulouse. He is Officer of the Order of Leopold II, Commander, Grand Officer of the Order of the Crown, Professor Extraordinary, Honorary of the ULg and Perpetual Secretary of the Royal Academy of Medicine of Belgium. He was also General Secretary of the European Society of Gynecology and member of multiple editorial boards of international peer-reviewed journals.
 
Ms. Valérie Gordenne holds a Master's degree in Pharmacy from the University of Liège.
She has over 20 years of experience in pharmaceutical Research & Development with extensive leadership experience in full drug development across a range of therapeutic areas, in particular in women's health (CSO Mithra, CEO Novalon, General Manager Odyssea). Through the management of various functions and activities, she has developed a deep operational and strategic knowledge and expertise in drug development. She is currently Chief Scientific Officer at Auxin Surgery, CEO of the start-up Odix and advisor in regulatory affairs.
Secretary of the Board
Compliance Officer
Mithra (Euronext: MITRA) is a Belgian biotech company dedicated to transforming women’s health by offering new choices through innovation, with a particular focus on contraception and menopause.
Mithra (Headquarter)
Rue Saint-Georges 5
4000 Liège
Belgium
+32 (0)4 349 28 22
info@mithra.com
Mithra CDMO
Rue de l’Expansion 57
4400 Flémalle
Belgium
+32 (0)4 353 37 00
info@mithracdmo.com